|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.975
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.968
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.962
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.954
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.934
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.924
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.872
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.870
|
|
|
|
follicle stimulating hormone secretion
|
GO:0046884 |
1 |
0.865
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.843
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.840
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.774
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.764
|
|
|
|
spermatogenesis exchange of chromosomal proteins
|
GO:0035093 |
4 |
0.733
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.705
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.692
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.661
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.653
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.649
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.628
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.583
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.582
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.579
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.576
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.549
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.515
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.507
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.501
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.487
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.485
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.471
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.442
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.428
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.399
|
|
|
|
follicle stimulating hormone signaling pathway
|
GO:0042699 |
3 |
0.399
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.396
|
|
|
|
positive regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033145 |
4 |
0.389
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.385
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.378
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.376
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.374
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.372
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.372
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.368
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.368
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.367
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.367
|
|
|
|
regulation of cgmp metabolic process
|
GO:0030823 |
12 |
0.365
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.364
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.359
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.350
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.349
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.348
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.346
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.346
|
|
|
|
regulation of female gonad development
|
GO:2000194 |
7 |
0.341
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.329
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.328
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.325
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.309
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.307
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.306
|
|
|
|
positive regulation of toll like receptor 4 signaling pathway
|
GO:0034145 |
1 |
0.303
|
|
|
|
antral ovarian follicle growth
|
GO:0001547 |
5 |
0.303
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.301
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.300
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.295
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.292
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.292
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.291
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.282
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.279
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.279
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.277
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.276
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.273
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.273
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.270
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.268
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.266
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.259
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.257
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.255
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.251
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.245
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.244
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.242
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.240
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.239
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.234
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.228
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.228
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.227
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.227
|
|
|
|
cellular response to ethanol
|
GO:0071361 |
3 |
0.226
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.223
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.221
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.220
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.218
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.217
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.214
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.214
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.208
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.208
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.207
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.205
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.204
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
17 |
0.201
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.190
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.188
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.186
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.184
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.183
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.179
|
|
|
|
negative regulation of bone resorption
|
GO:0045779 |
6 |
0.178
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.177
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.177
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.176
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.176
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.173
|
|
|
|
l serine metabolic process
|
GO:0006563 |
2 |
0.172
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.171
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.170
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.169
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.166
|
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.165
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.164
|
|
|
|
succinate metabolic process
|
GO:0006105 |
4 |
0.164
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.163
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.162
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.161
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.160
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.159
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.159
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.159
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.156
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.153
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.153
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.151
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.149
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.148
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.144
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
12 |
0.144
|
|
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.144
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.141
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.140
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.140
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.140
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.140
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.138
|
|
|
|
negative regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903556 |
17 |
0.133
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.133
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.133
|
|
|
|
female genitalia development
|
GO:0030540 |
14 |
0.133
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.132
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.130
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.130
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.128
|
|
|
|
regulation of inositol trisphosphate biosynthetic process
|
GO:0032960 |
3 |
0.128
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.127
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.124
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.124
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.124
|
|
|
|
seminiferous tubule development
|
GO:0072520 |
14 |
0.123
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.123
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.123
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.122
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.122
|
|
|
|
canonical wnt signaling pathway involved in metanephric kidney development
|
GO:0061290 |
2 |
0.121
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.121
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.121
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.120
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.119
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.116
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.116
|
|
|
|
luteinization
|
GO:0001553 |
8 |
0.114
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.113
|
Zebrafish |
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.113
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.112
|
|
|
|
positive regulation of cholesterol homeostasis
|
GO:2000189 |
2 |
0.111
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.111
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.110
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
5 |
0.108
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.108
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.108
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.107
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.105
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.105
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.105
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.105
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.103
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.103
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.102
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.102
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.102
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.101
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.100
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.100
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.099
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.099
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.099
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.098
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.098
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.096
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.096
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.095
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.095
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.095
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.095
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.095
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.092
|
|
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
8 |
0.091
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.091
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.091
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.090
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.090
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.089
|
|
|
|
serine family amino acid metabolic process
|
GO:0009069 |
7 |
0.089
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.089
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.089
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.087
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.087
|
|
|
|
positive regulation of retinoic acid receptor signaling pathway
|
GO:0048386 |
3 |
0.086
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.086
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.085
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.085
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.084
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.084
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.083
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.083
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.082
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.081
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.081
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.081
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.081
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.081
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.080
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.080
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.080
|
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.080
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.080
|
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.079
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.079
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.078
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.077
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.077
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.076
|
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.076
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.076
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.076
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.075
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.075
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.075
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.074
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
22 |
0.073
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.073
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.073
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.073
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.072
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.072
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.072
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.071
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.071
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.071
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.070
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.069
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.069
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.068
|
|
|
|
inositol phosphate biosynthetic process
|
GO:0032958 |
6 |
0.067
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.067
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.067
|
|
|
|
sertoli cell proliferation
|
GO:0060011 |
5 |
0.067
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.067
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.066
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.066
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.066
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.066
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.066
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.066
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.065
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.065
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.065
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.065
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.065
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.065
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.065
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.065
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.065
|
|
|
|
glutamine family amino acid metabolic process
|
GO:0009064 |
15 |
0.065
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.064
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.064
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.064
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.064
|
|
|
|
negative regulation of bone remodeling
|
GO:0046851 |
6 |
0.064
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.064
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.064
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.064
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.063
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
6 |
0.063
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.063
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.063
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.062
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.062
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.062
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.061
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.061
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.060
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.060
|
|
|
|
cellular senescence
|
GO:0090398 |
11 |
0.060
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.060
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.060
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.060
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.059
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.059
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.059
|
|
|
|
primary ovarian follicle growth
|
GO:0001545 |
2 |
0.059
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.058
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.058
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.057
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.057
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.057
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.057
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.056
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.056
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.056
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.056
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.056
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.056
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.055
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.055
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.055
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.055
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.054
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.054
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.054
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.054
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.053
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.052
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.052
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.052
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.052
|
|
|
|
corpus callosum development
|
GO:0022038 |
10 |
0.052
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.052
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.052
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.052
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.051
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.051
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.051
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.051
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.051
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.051
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.051
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.050
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.050
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.050
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.050
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.050
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.050
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.050
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.050
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.050
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.049
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.049
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.049
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.049
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.049
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.049
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.049
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.048
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.048
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.048
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.048
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.048
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.048
|
|
|
|
creatinine metabolic process
|
GO:0046449 |
3 |
0.048
|
|
|
|
maintenance of protein localization in organelle
|
GO:0072595 |
2 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
prostate gland growth
|
GO:0060736 |
13 |
0.047
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.047
|
|
|
|
regulation of tolerance induction to self antigen
|
GO:0002649 |
1 |
0.047
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.047
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
6 |
0.047
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.047
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.047
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
15 |
0.046
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.046
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.046
|
|
|
|
trophectodermal cell proliferation
|
GO:0001834 |
2 |
0.046
|
|
|
|
regulation of semaphorin plexin signaling pathway
|
GO:2001260 |
1 |
0.046
|
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.046
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.046
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.046
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.046
|
|
|
|
megakaryocyte development
|
GO:0035855 |
15 |
0.046
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.046
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.046
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.046
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
20 |
0.045
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.045
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.045
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.045
|
|
|
|
sulfur amino acid biosynthetic process
|
GO:0000097 |
5 |
0.045
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.045
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.045
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.045
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.044
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.044
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.044
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.043
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.043
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.043
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.043
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.043
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.043
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.042
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.042
|
|
|
|
cell cell signaling involved in metanephros development
|
GO:0072204 |
2 |
0.042
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.042
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.042
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.042
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.042
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.042
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.042
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.041
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.041
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.041
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.040
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.040
|
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.040
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.040
|
|
|
|
negative regulation of female gonad development
|
GO:2000195 |
3 |
0.039
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.039
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.039
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.039
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.039
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
17 |
0.039
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.038
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.038
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.038
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.038
|
|
|
|
negative regulation of protein secretion
|
GO:0050709 |
20 |
0.038
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.038
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
13 |
0.038
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.038
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.038
|
|
|
|
cellular response to stem cell factor stimulus
|
GO:0036216 |
3 |
0.038
|
|
|
|
steroid hormone mediated signaling pathway
|
GO:0043401 |
6 |
0.038
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.038
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.038
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
16 |
0.038
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.037
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.037
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
8 |
0.037
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.037
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.037
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.037
|
|
|
|
exit from mitosis
|
GO:0010458 |
3 |
0.037
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.037
|
|
|
|
vagina development
|
GO:0060068 |
11 |
0.037
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.037
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.037
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.037
|
|
|
|
positive regulation of inositol trisphosphate biosynthetic process
|
GO:0032962 |
2 |
0.037
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.036
|
|
|
|
negative regulation of macrophage activation
|
GO:0043031 |
2 |
0.036
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.036
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.036
|
|
|
|
taurine metabolic process
|
GO:0019530 |
4 |
0.036
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.035
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.035
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.035
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.035
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.035
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.035
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.035
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.035
|
|